A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination

Obstetrics and Gynecology

Volumn 93, Issue 4 SUPPL., 1999, Pages 571-575

  Jain, John K ^a,b   Kuo, John ^a   Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; CARBOPROST TROMETAMOL; METHYLERGOMETRINE MALEATE; MISOPROSTOL; PARACETAMOL; PETHIDINE; PROCHLORPERAZINE; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DIARRHEA; DRUG EFFICACY; FEMALE; FETUS DEATH; FEVER; GESTATIONAL AGE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; LAMINARIA; MAJOR CLINICAL STUDY; PAIN; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 0032974303     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-199904000-00019     Document Type: Article

References (16)

1. Toppozada M, Ismail AA. Intrauterine administration of drugs for termination of pregnancy in the second trimester. Baillieres Clin Obstet Gynaecol 1990;4:327-49.
2. Mishell DR Jr. Induced abortion. In: Berkow K, ed. The Merck manual of diagnosis and therapy. 16th ed. Rahway, New Jersey. Merck Research Laboratories, 1992:1781-3.
3. Grimes DA, Cates W Jr. Complications from legally-induced abortion: A review. Obstet Gynecol Surv 1979;34:177-91.
4. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: An analysis of 11,747 cases. Obstet Gynecol 1983;62:185-90.
5. Wadhera S, Millar WJ. Second trimester abortions: Trends and medical complications. Health Rep 1994;6:441-54.
6. MacKay HT, MacKay AP. Abortion training in obstetrics and gynecology residency programs in the United States, 1991-1992. Fam Plann Perspect 1945;27:112-5.
7. Westhoff C, Marks F, Rosenfield A. Residency training in contraception, sterilization, and abortion. Obstet Gynecol 1993;81:311-4.
8. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:537-40.
9. Herting RL, Nissen CH. Overview of misoprostol clinical experience. Dig Dis Sci 1986;31(suppl 2):47S-54S.
10. el-Refacy H, Calder L, Wheatley DN, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994;343:1207-4.
11. Jain JK, Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester preg-nancy. N Engl J Med 1994;331:290-3.
12. Jain JK, Mishell DR Jr. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obsyet Gynecol 1996;175:173-7.
13. Shepard MJ, Richards VA, Berkowitz RL, Warsof SL, Hobbins JC. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol 1982;142:47-54.
14. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs. New Jersey: Prentice-Hall, 1984.
15. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
16. el-Refaey H, Templeton A. Induction of abortion in the second randomized by a combination of misprostol and mifepristone: A randomized comparison between two misoprostol regimens. Hum Reprod 1995;10:473-8.